Diagnostic and Practical Challenges in Applying National Comprehensive Cancer Network Guidelines for Suspected Pathogenic TP53 Mosaicism.
Daniel I NathanTehilla E BranderJulie GoldDeborah PaulPaula KleinKit ChengJohnson M LiuBridget K MarcellinoPublished in: JCO precision oncology (2024)
Benefits and limitations in using NCCN guidelines to distinguish TP53 CH from mosaic LFS.